These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 4079497)

  • 61. Bimonthly update: lipidology. Therapy and clinical trials.
    Cater N; Jialal I
    Curr Opin Lipidol; 1997 Dec; 8(6):U88-9. PubMed ID: 9440935
    [No Abstract]   [Full Text] [Related]  

  • 62. Cholesterol lowering. Should it continue to be the last thing we do?
    Waters D
    Circulation; 1999 Jun; 99(25):3215-7. PubMed ID: 10385491
    [No Abstract]   [Full Text] [Related]  

  • 63. Cholesterol and cardiovascular disease: current perspectives. Introduction and overview.
    Steinberg D
    Circulation; 1987 Sep; 76(3):502-3. PubMed ID: 3621515
    [No Abstract]   [Full Text] [Related]  

  • 64. Improvement in endothelial dysfunction with LDL cholesterol level < 80 mg/dl in type 2 diabetic patients.
    Sheu WH; Chen YT; Lee WJ
    Diabetes Care; 2001 Aug; 24(8):1499-501. PubMed ID: 11473096
    [No Abstract]   [Full Text] [Related]  

  • 65. National cholesterol education program (NCEP) guidelines too complex.
    Feeman WE
    Prev Cardiol; 2005; 8(3):188. PubMed ID: 16108130
    [No Abstract]   [Full Text] [Related]  

  • 66. Therapy and clinical trials.
    Feher MD
    Curr Opin Lipidol; 1996 Dec; 7(6):U209-13. PubMed ID: 9117135
    [No Abstract]   [Full Text] [Related]  

  • 67. What are the priorities for managing cholesterol effectively?
    Brown WV
    Am J Cardiol; 2001 Aug; 88(4A):21F-4F. PubMed ID: 11520483
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Serum cholesterol levels in Puerto Rican volunteer blood donors.
    Marcial MA; Fernández Carbia A
    Bol Asoc Med P R; 1989 Aug; 81(8):297-9. PubMed ID: 2765045
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension.
    Levy D; Walmsley P; Levenstein M
    Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cholesterol: myth or reality?
    Thompson WG
    South Med J; 1990 Apr; 83(4):435-40. PubMed ID: 2181692
    [No Abstract]   [Full Text] [Related]  

  • 71. [Is hypolipemic treatment effective as a preventive measure?].
    Rywik S
    Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917
    [No Abstract]   [Full Text] [Related]  

  • 72. [Letter on the article: "Which lipid profiles and how to interpret in patients with coronary heart disease?"].
    Ambrosi P
    Presse Med; 2010 Feb; 39(2):286-7. PubMed ID: 20074902
    [No Abstract]   [Full Text] [Related]  

  • 73. High-density lipoprotein cholesterol therapies: the next frontier in lipid management.
    Duffy D; Rader DJ
    J Cardiopulm Rehabil; 2006; 26(1):1-8. PubMed ID: 16617219
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver].
    Simon K; Kowalewski W; Dobracki W
    Przegl Lek; 1987; 44(11):746-50. PubMed ID: 3447241
    [No Abstract]   [Full Text] [Related]  

  • 75. Hypercholesterolemia: a reversible risk factor for coronary heart disease.
    Mishkel MA
    CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008
    [No Abstract]   [Full Text] [Related]  

  • 76. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
    Labreche DG
    Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850
    [No Abstract]   [Full Text] [Related]  

  • 77. HDL cholesterol studies--more of the same?
    Després JP
    Nat Rev Cardiol; 2013 Feb; 10(2):70-2. PubMed ID: 23319099
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevention. Who should take cholesterol-lowering drugs?
    Harv Health Lett; 1998 Jan; 23(3):1-3. PubMed ID: 9650517
    [No Abstract]   [Full Text] [Related]  

  • 79. Prognostic and therapeutic significance of low levels of high-density lipoprotein cholesterol: current perspectives.
    Gotto AM
    Arch Intern Med; 1999 May; 159(10):1038-40. PubMed ID: 10335679
    [No Abstract]   [Full Text] [Related]  

  • 80. [Diet in the treatment of atherogenic dyslipoproteinemias].
    Oganov RG; Perova NV
    Kardiologiia; 1990 May; 30(5):5-7. PubMed ID: 2391809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.